CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013–2016)
Authors
Amber R. Atwater
Donald V. Belsito
+14 more
Joel G. Dekoven
Vincent A. Deleo
Joseph F. Fowler
Rachit Gupta
Howard I. Maibach
James G. Marks
Melanie D. Pratt
Margo J. Reeder
Denis Sasseville
Jonathan I. Silverberg
James S. Taylor
Erin M. Warshaw
Matthew J. Zirwas
Kathryn A. Zug
Publication date
1 November 2020
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi
Cite
Abstract
© Lippincott Williams & Wilkins. Background/Objectives Carba mix (CM, 3% petrolatum) contains 1,3-diphenylguanidine (DPG, 1%), zinc diethyldithiocarbamate (1%), and zinc dibutyldithiocarbamate (1%). Because DPG is a component of CM, DPG is often not tested separately. The purpose of this study was to determine the frequency of concomitant reactions to CM and DPG. Methods A retrospective analysis of the 2013-2016 North American Contact Dermatitis Group data was conducted. The study group consisted of patients with final interpretation of allergic to either DPG or CM. Reactions coded as irritant or doubtful/macular erythema (+/- and not interpreted as allergic) were excluded. Results A total of 10,457 patients were patch tested to both CM and DPG, and 610 (5.8%) had allergic reactions to either CM or DPG (CM only [n = 292, 47.9%], DPG only [n = 190, 31.1%], both [n = 128, 21.0%]). A total of 39.4% of CM-allergic patients reacted to DPG, and 59.7% of DPG-allergic patients reacted to CM. Analyses found that 25% (++/+++ subgroup) to 40% (all patients) of allergic reactions to DPG would have been missed by testing to CM alone. More than 70% of reactions to CM and DPG were +/- or +. Conclusions Patch testing to CM will miss 25% to 40% of positive reactions to DPG. Both CM and DPG have a high frequency of +/- and + reactions
Similar works
Full text
Available Versions
George Washington University: Health Sciences Research Commons (HSRC)
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:hsrc.himmelfarb.gwu.edu:sm...
Last time updated on 19/04/2021
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 01/05/2021